{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:57:23Z","timestamp":1772344643365,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation (NRF) of South Africa","doi-asserted-by":"publisher","award":["129774"],"award-info":[{"award-number":["129774"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sandisa Imbewu"},{"DOI":"10.13039\/501100001333","name":"Rhodes University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001333","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: Cocrystallisation is a well-established path for altering the physicochemical properties and bioavailability of active pharmaceutical ingredients (APIs). A common side effect of anti-tubercular medicines is the depletion of group B vitamin reserves in TB patients. Co-administration of supplements such as pyridoxine (vitamin B6) during TB therapy may be used to ameliorate the harmful side effects of vitamin B6 deficiency. Methods: Mechanochemical grinding and solvent evaporation experiments using pyridoxine (PN) with 4-aminosalicylic acid (PAS) and separately with pyrazinecarboxylic acid (PCBA) were conducted. The bulk powder and crystal analysis was performed using FTIR, PXRD, DSC, TGA and SCXRD. Results: The isolation and characterization of two multicomponent salts containing pyridoxine, i.e., PN-PAS\u00b7H2O and PN-PCBA, were completed. Mechanochemistry is an efficient method for the preparation of cocrystals. Conclusions: The drug\u2013vitamin combinations may be useful for the development of new treatment regimens with potentially improved therapeutic outcomes and reduced adverse effects.<\/jats:p>","DOI":"10.3390\/pharmaceutics18030297","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:52:38Z","timestamp":1772207558000},"page":"297","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive Multicomponent Crystals of Two Anti-Tubercular Drugs with Pyridoxine"],"prefix":"10.3390","volume":"18","author":[{"given":"Tsebang A.","family":"Matlapeng","sequence":"first","affiliation":[{"name":"Department of Chemistry, Rhodes University, Makhanda 6140, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4888-0353","authenticated-orcid":false,"given":"Theodor E.","family":"Geswindt","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Rhodes University, Makhanda 6140, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-4154","authenticated-orcid":false,"given":"Roderick B.","family":"Walker","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Rhodes University, Makhanda 6140, South Africa"},{"name":"School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University, Aberdeen AB10 7AQ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0180-1002","authenticated-orcid":false,"given":"Vincent J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Rhodes University, Makhanda 6140, South Africa"},{"name":"Department of Chemistry and Polymer Science, Stellenbosch University, Stellenbosch 7599, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025). Global Tuberculosis Report 2025, World Health Organization."},{"key":"ref_2","first-page":"910","article-title":"Isoniazid-Induced Vitamin B6 Deficiency: Metabolic Studies and Preliminary Vitamin B6 Excretion Studies","volume":"96","author":"Levy","year":"1967","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ccm.2019.08.002","article-title":"Treatment of Drug-Resistant Tuberculosis","volume":"40","author":"Mase","year":"2019","journal-title":"Clin. Chest Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2012.02.033","article-title":"Tuberculosis: The drug development pipeline at a glance","volume":"51","author":"Villemagne","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_6","first-page":"186","article-title":"New drugs and new regimens for the treatment of tuberculosis: Review of the drug development pipeline and implications for national programmes","volume":"16","author":"Lienhardt","year":"2010","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1039\/B919819A","article-title":"Recent advances in crystal engineering","volume":"12","author":"Champness","year":"2010","journal-title":"CrystEngComm"},{"key":"ref_8","first-page":"569","article-title":"Crystal engineering: Strategies and architectures","volume":"53","year":"1997","journal-title":"Struct. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/ar010054t","article-title":"Hydrogen bridges in crystal engineering: Interactions without borders","volume":"35","author":"Desiraju","year":"2002","journal-title":"Acc. Chem. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2012.11.028","article-title":"Use of pharmaceutical salts and cocrystals to address the issue of poor solubility","volume":"453","author":"Elder","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.1021\/acs.jpcb.5b05082","article-title":"Influence of Secondary Interactions on the Structure, Sublimation Thermodynamics, and Solubility of Salicylate:4-Hydroxybenzamide Cocrystals. Combined Experimental and Theoretical Study","volume":"119","author":"Manin","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/acs.molpharmaceut.3c01059","article-title":"Quabodepistat (opc-167832), a novel antituberculosis drug candidate: Enhancing oral bioavailability via cocrystallization and mechanistic analysis of bioavailability in two cocrystals","volume":"21","author":"Sakamoto","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"54553","DOI":"10.1021\/acsami.5c13207","article-title":"Strategic Modulation of Isoniazid Solubility through Cocrystal Formation for Long-Acting Microneedle Therapy of Tuberculosis","volume":"17","author":"McPeake","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.cgd.4c01323","article-title":"Pharmaceutical Cocrystals and Salt of Ethionamide with Fluorobenzoic Acids for Improved Drug Delivery","volume":"24","author":"Veeranagaiah","year":"2024","journal-title":"Cryst. Growth Des."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"126523","DOI":"10.1016\/j.jcrysgro.2022.126523","article-title":"Hepatoprotective cocrystal of ethionamide: A new attempt to refurbish old drug through crystal engineering","volume":"582","author":"Li","year":"2022","journal-title":"J. Cryst. Growth"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejps.2016.12.016","article-title":"Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies","volume":"99","author":"Drozd","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_17","unstructured":"McNaught, A.D., and Wilkinson, A. (1997). Compendium of Chemical Terminology (the \u201cGold Book\u201d), Scientific Publications. [2nd ed.]."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/cssc.202100478","article-title":"Sustainability assessment of mechanochemistry by using the twelve principles of green chemistry","volume":"14","year":"2021","journal-title":"ChemSusChem"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13216","DOI":"10.1073\/pnas.0915142107","article-title":"Tunable recognition of the steroid \u03b1-face by adjacent \u03c0-electron density","volume":"107","author":"Lancaster","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1039\/p29950002213","article-title":"Selective formation of hydrogen bonded cocrystals between a sulfonamide and aromatic carboxylic acids in the solid state","volume":"2","author":"Caira","year":"1995","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/acs.cgd.9b01450","article-title":"Cocrystals: Solution, Mechanochemistry and Sublimation","volume":"20","author":"Carstens","year":"2019","journal-title":"Cryst. Growth Des."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1021\/acs.chemrev.1c00987","article-title":"Crystal engineering of pharmaceutical cocrystals in the discovery and development of improved drugs","volume":"122","author":"Bolla","year":"2022","journal-title":"Chem. Rev."},{"key":"ref_23","unstructured":"WHO (2019). Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment, World Health Organization."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cardona, P.-J. (2012). Understanding Tuberculosis\u2014New Approaches to Fighting Against Drug Resistance, InTech.","DOI":"10.5772\/2477"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.13207","article-title":"B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin","volume":"26","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"ref_26","unstructured":"Bruker (2016). APEX4, SAINT and SADABS, Bruker AXS Inc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT\u2014Integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. A Found. Adv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal Structure Refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. C Struct. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-7862(02)00030-8","article-title":"X-Seed\u2014A software tool for supramolecular crystallography","volume":"1","author":"Barbour","year":"2001","journal-title":"J. Supramol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar00172a005","article-title":"Encoding and decoding hydrogen-bond patterns of organic compounds","volume":"23","author":"Etter","year":"1990","journal-title":"Acc. Chem. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1107\/S0108768189012929","article-title":"Graph-set analysis of hydrogen-bond patterns in organic crystals","volume":"46","author":"Etter","year":"1990","journal-title":"Acta Cryst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/jps.2600741207","article-title":"Mechanism of decarboxylation of p-aminosalicylic acid","volume":"74","author":"Jivani","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s10973-019-08958-3","article-title":"Mechanochemical synthesis, characterization and thermal study of new cocrystals of ciprofloxacin with pyrazinoic acid and p-aminobenzoic acid: AC de Almeida et al","volume":"140","author":"Ferreira","year":"2020","journal-title":"J. Therm. Anal. Calorim."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/3\/297\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:13:17Z","timestamp":1772341997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/3\/297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["pharmaceutics18030297"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18030297","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}